Germany's BioNTech to buy CureVac to boost cancer research
- ANDRE PAIN
- 0
BioNTech hopes its purchase of CureVac will help boost its research into cancer treatments
ANDRE PAINTags
- Afp
- Biontech
- Curevac
- Biotechnology
- Public Health
- Medical Specialties
- Immunology
- Vaccination
- Health Sciences
- Covid-19 Vaccines
- Life Sciences
- Medicine
- Vaccines
- Drugs
- Preventive Medicine
- Health
- Uğur Şahin
- Clinical Medicine
- Vaccine
- Covid-19 Vaccine
- Pediatrics
- Covid-19 Drug Development
- Biology
- Medical Treatments
- Infectious Diseases
As featured on
Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Th…
Post a comment as anonymous
Report
Watch this discussion. Stop watching this discussion.
Most Popular
-
Authorities investigating body found inside of burning camper trailer in Dallas County
-
Land bank to help clear derelict houses in Selma may be a step closer to reality
-
Perry County man sentenced to 75 years in 2021 killing of his wife
-
Grand marshals announced for Selma Christmas Parade
-
Why every growing community needs a city planner, including Demopolis and Linden
Local Events
Currently in Selma
36°
Sunny
36° / 30°
9 AM
43°
10 AM
51°
11 AM
57°
12 PM
63°
1 PM
65°
Get Black Belt News headlines for free in your inbox every day!
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
© Copyright 2025
Black Belt News Network
127A Broad Street,, Selma, AL
| Terms of Use
| Privacy Policy
Powered by BLOX Content Management System from BLOX Digital.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.